Explora Foundation signs the Armed Forces Covenant.
The Explora Foundation has signed the Armed Forces Covenant at an event that took place on Wednesday 3 October 2018 at Lincoln’s Inn Army Reserve Centre, London.
The Covenant was co-signed by Major General Ben Bathurst, General Officer Commanding London District, on behalf of the Ministry of Defence.
Following the signing, the London Ballet Company gave a moving performance of a specially adapted WW1 piece, entitled Poppy.
Francis LeCarpentier, representing the foundation, stated: “Signing the Armed Forces Covenant today is an obvious step for the foundation given its driving principles and objectives. It confirms our ethos, practice and conviction of responsibility to those who serve, have served and their families.”
One recipient of an Explora Foundation scholarship, who attended the event, is Captain Dave Henson, ex-Royal Engineers. Dave is currently studying for a PhD in Bioengineering at the Imperial College London. Dave stated “It is fantastic to see the values and standards of our Armed Forces echoed and respected in industry through this public signing of the covenant; a public recognition of the inherent transferable skills and wealth of knowledge held in the personnel of our military.”
A promise by the nation.
To those who proudly protect our nation, who do so with honour, courage, and commitment, the Armed Forces Covenant is the nation’s commitment to you.
It is a pledge that together we acknowledge and understand that those who serve or who have served in the Armed Forces, and their families, should be treated with fairness and respect in the communities, economy and society they serve with their lives.
We, the people, recognise this duty to you who so bravely do yours.
The Armed Forces Covenant is a promise from
the nation to those who serve. It says we will do
all we can to ensure they are treated fairly and
not disadvantaged in their day-to-day lives. This includes offering injured servicemen and women and bereaved families extra support where appropriate.